Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A

Published:2014-03-31 Issue:12 Volume:21 Page:1391-1404
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Gentile I.,Borgia F.,Coppola N.,Buonomo A.R.,Castaldo G.,Borgia G.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa;EMBO Molecular Medicine;2024-03-10

2. Validated Stability-Indicating RP-HPLC Method for Daclatasvir in Tablets;Turkish Journal of Pharmaceutical Sciences;2022-10-18

3. Three Smart and Original Spectrophotometric Data Processing Ratio Techniques for Resolving the Partial Overlapped Spectra of the Binary Antiviral Mixture Daclatasvir/Sofosbuvir: Application to Combined Dosage Form Darvoni® Tablets;Journal of AOAC INTERNATIONAL;2021-12-10

4. RP-HPLC method development and validation for quantification of daclatasvir dihydrochloride and its application to pharmaceutical dosage form;pakistan journal of pharmaceutical sciences;2021-05-01

5. Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C;Expert Opinion on Pharmacotherapy;2020-01-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP